cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2020-2441cardiovascular-2441Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEW ARTICLESПроблема стратификации сердечно-сосудистого риска в зависимости от выраженности атеросклероза сонных и бедренных артерийThe problem of cardiovascular risk stratification depending on the severity of carotid and femoral artery atherosclerosishttps://orcid.org/0000-0001-7989-0760ЕршоваА. И.ErshovaA. I.

Ершова Александра Игоревна — кандидат медицинских наук, руководитель лаборатории клиномики.

Москва

Moscow

alersh@mail.ruhttps://orcid.org/0000-0002-7273-6979БалахоноваТ. В.BalakhonovaT. V.

Балахонова Татьяна Валентиновна — профессор, доктор медицинских наук, главный научный сотрудник отдела ультразвуковых методов исследований Института клинической кардиологии им. А. Л. Мясникова.

Moscow

tvbdoc@gmail.comhttps://orcid.org/0000-0002-2812-959XИвановаА. А.IvanovaA. A.

Иванова Анна Александровна — студентка 6 курса ИКМ.

Москва, Тел.: +7 (926) 214-74-68

Moscow

annaivanova12121@yandex.ruhttps://orcid.org/0000-0001-5989-6233МешковА. Н.MeshkovA. N.

Мешков Алексей Николаевич — кандидат медицинских наук, руководитель лаборатории молекулярной генетики.

Москва

Moscow

meshkov@lipidclinic.ruhttps://orcid.org/0000-0001-6998-8406БойцовС. А.BoytsovS. A.

Бойцов Сергей Анатольевич — доктор медицинских наук, профессор, член-корр. РАН, генеральный директор.

Москва

Moscow

prof.boytsov@gmail.comhttps://orcid.org/0000-0002-4453-8430ДрапкинаО. М.DrapkinaO. M.

Драпкина Оксана Михайловна — доктор медицинских наук, профессор, член-корр. РАН, директор.

Москва

Moscow

drapkina@bk.ruФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава РоссииNational Medical Research Center for Therapy and Preventive Medicine.ФГБУ Национальный медицинский исследовательский центр кардиологии Минздрава РоссииNational Medical Research Center of Cardiology.ФГАОУ ВО Первый МГМУ им. И. М. Сеченова Минздрава России (Сеченовский университет)I.M. Sechenov First Moscow State Medical UniversityФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава РоссииNational Medical Research Center for Therapy and Preventive MedicineФГБУ Национальный медицинский исследовательский центр кардиологии Минздрава РоссииNational Medical Research Center of Cardiology20202004202019224412441Copyright © Ершова А.И., Балахонова Т.В., Иванова А.А., Мешков А.Н., Бойцов С.А., Драпкина О.М., 20202020Ершова А.И., Балахонова Т.В., Иванова А.А., Мешков А.Н., Бойцов С.А., Драпкина О.М.Ershova A.I., Balakhonova T.V., Ivanova A.A., Meshkov A.N., Boytsov S.A., Drapkina O.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/2441

В настоящее время представления об атеросклерозе сонных и бедренных артерий претерпели ряд изменений. С одной стороны, каротидный, как и феморальный атеросклероз — это болезнь, которую непосредственно надо лечить, с другой стороны, — это модификатор сердечно-сосудистого риска. Данный обзор посвящен аспектам стратификации сердечно-сосудистого риска в зависимости от выраженности и скорости прогрессирования атеросклеротического процесса в сонных и бедренных артериях.

Currently, the concept of atherosclerosis has undergone a number of changes. On the one hand, carotid atherosclerosis, like femoral, is a disease that must be treated directly, and on the other hand, it is a modifier of cardiovascular risk. This review is devoted to aspects of cardiovascular risk stratification depending on the severity and progression of carotid and femoral artery atherosclerosis.

атеросклеротическая бляшкасонные артериибедренные артериивысокий сердечно-сосудистый рискatherosclerotic plaquecarotid arteriesfemoral arterieshigh cardiovascular riskReferencesДиагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации VI пересмотр. Атеросклероз и дислипидемии. 2017;3(28):5-23.37 Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33( 12):2916-22. doi: 10.1161/01.str.000004220716156.b9.Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019 Aug 31. pii: ehz455. doi:10.1093/eurheartj/ehz455.Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations VI revision. Atherosclerosis and dyslipidemias. 2017;3(28):5-23. (In Russ.)Polonsky TS, Greenland P. CVD screening in low-risk, asymptomatic 7. adults: clinical trials needed. Nat Rev Cardiol. 2012;9(10):599-604. doi:10.1038/nrcardio.2012.114.Boulos NM, Gardin JM, Malik S, et al. Carotid Plaque Characterization, Stenosis, and Intima-Media Thickness According to Age and Gender in a Large Registry Cohort. Am J Cardiol. 2016; 117(7): 1185-91. doi:101016/j.amjcard.2015.12.062.Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth 8. Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association 9. for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. doi:10.1093/eurheartj/ehw106.Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019 Aug 31. pii: ehz455. doi:10.1093/eurheartj/ehz455.. Spence JD, Hackam DG. Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis. Stroke. 2010;41(6):1193-9. doi:10.1161/STROKEAHA.110.577973.Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012; 308( 8): 796-803. doi: 10.1001/jama.2012.9630.Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816. doi :10.1093/eurheartj/ehx095.Polonsky TS, Greenland P. CVD screening in low-risk, asymptomatic 7. adults: clinical trials needed. Nat Rev Cardiol. 2012;9(10):599-604. doi:10.1038/nrcardio.2012.114.Brinjikji W, Rabinstein AA, Lanzino G, et al. Ultrasound Characteristics of Symptomatic Carotid Plaques: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2015;40(3-4): 165-74. doi:10.1159/000437339.Ezhov MV, Sergienko IV, Rozhkova TA, et al. Diagnosis and treatment of family hypercholesterolemia (russian guidelines). The Bulletin of Contemporary Clinical Medicine. 2017; 10(2):72-9. (In Russ.) doi:10.20969/VSKM.201710(2).72-79.de Weerd M, Greving JP, de Jong AW, et al. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke. 2009;40(4): 1105-13. doi:10.1161/STROKEAHA.108.532218.Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth 8. Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association 9. for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. doi:10.1093/eurheartj/ehw106.Ершова А. И., Мешков А. Н., Деев А. Д. и др. Атеросклеротическая бляшка в сонных артериях как маркер риска развития сердечно-сосудистых событий в популяции среднего возраста. Кардиоваскулярная терапия и профилактика. 2018;17(4):34-9. doi:10.15829/1728-8800-2018-4-34-39.. Spence JD, Hackam DG. Treating arteries instead of risk factors: a paradigm change in management of atherosclerosis. Stroke. 2010;41(6):1193-9. doi:10.1161/STROKEAHA.110.577973.Postley JE, Luo Y, Wong ND, et al. Identification by ultrasound evaluation of the carotid and femoral arteries of high-risk subjects missed by three validated cardiovascular disease risk algorithms. Am J Cardiol. 2015;116(10):1617-23. doi:10.1016/j.amjcard.2015.08.031.Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816. doi :10.1093/eurheartj/ehx095.Gepner AD, Young R, Delaney JA, et al. Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2015;8( 1). pii: e002262. doi: 10.1161/CIRCIMAGING.114.002262.Brinjikji W, Rabinstein AA, Lanzino G, et al. Ultrasound Characteristics of Symptomatic Carotid Plaques: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2015;40(3-4): 165-74. doi:10.1159/000437339.Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010;55( 15): 1600-7 doi:10.1016/j.jacc.2009.11.075.de Weerd M, Greving JP, de Jong AW, et al. Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis. Stroke. 2009;40(4): 1105-13. doi:10.1161/STROKEAHA.108.532218.Polak JF, Pencina MJ, Pencina KM, et al. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011; 365(3):213-21. doi:10.1056/NEJMoa1012592.Ershova AI, Meshkov AN, Deev AD, et al. Atherosclerotic plaque in carotid arteries as a risk marker for cardiovascular events risk in middle aged population. Cardiovascular Therapy and Prevention. 2018;17(4):34-9. (In Russ.) doi:10.15829/1728-8800-2018-4-34-39.Baber U, Mehran R, Sartori S, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol. 2015;65:1065-74. doi: 10.1016/j.jacc.2015.01.017.Postley JE, Luo Y, Wong ND, et al. Identification by ultrasound evaluation of the carotid and femoral arteries of high-risk subjects missed by three validated cardiovascular disease risk algorithms. Am J Cardiol. 2015;116(10):1617-23. doi:10.1016/j.amjcard.2015.08.031.Peters SA, den Ruijter HM, Bots ML, et al. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart. 2012;98(3):177-84. doi:10.1136/heartjnl-2011-300747.Gepner AD, Young R, Delaney JA, et al. Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2015;8( 1). pii: e002262. doi: 10.1161/CIRCIMAGING.114.002262.Zhang Y, Fang X, Hua Y, et al. Carotid Artery Plaques, Carotid Intima-Media Thickness, and Risk of Cardiovascular Events and All-Cause Death in Older Adults: A 5-Year Prospective, Community-Based Study. Angiology. 2018; 69( 2): 120-9. doi:10.1177/0003319717716842.Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010;55( 15): 1600-7 doi:10.1016/j.jacc.2009.11.075.Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis. 2012;220(1): 128-33. doi: 10.1016/j.atherosclerosis.2011.06.044.Polak JF, Pencina MJ, Pencina KM, et al. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011; 365(3):213-21. doi:10.1056/NEJMoa1012592.Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31(7):883-91. doi:10.1093/eurheartj/ehp546.Baber U, Mehran R, Sartori S, et al. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol. 2015;65:1065-74. doi: 10.1016/j.jacc.2015.01.017.Yerly P, Rodondi N, Viswanathan B, et al. Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population. Int J Cardiovasc Imaging. 2013;29(3):589-99. doi:10.1007/s10554-012-0124-3.Peters SA, den Ruijter HM, Bots ML, et al. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart. 2012;98(3):177-84. doi:10.1136/heartjnl-2011-300747.Laclaustra M, Casasnovas JA, Fernandez-Ortiz A, et al. Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study. J Am Coll Cardiol. 2016; 67 (1 1): 1263-74. doi: 10.1016/j.jacc.2015.12.056.Zhang Y, Fang X, Hua Y, et al. Carotid Artery Plaques, Carotid Intima-Media Thickness, and Risk of Cardiovascular Events and All-Cause Death in Older Adults: A 5-Year Prospective, Community-Based Study. Angiology. 2018; 69( 2): 120-9. doi:10.1177/0003319717716842.Held C, Hjemdahl P, Eriksson SV, et al. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J. 2001;22(1):62-72. doi:10.1053/euhj.1999.2006.17 Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis. 2012;220(1): 128-33. doi: 10.1016/j.atherosclerosis.2011.06.044.Colledanchise KN, Mantella LE, Bullen M, et al. Combined Femoral and Carotid Plaque Burden Identifies Obstructive Coronary Artery Disease in Women. J Am Soc Echocardiogr. 2019 Oct 10. pii: S0894-7317(19)3091 1-3. doi:10.1016/j.echo.2019.07024.Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31(7):883-91. doi:10.1093/eurheartj/ehp546.Мешков А. Н., Ершова А. И., Деев А.Д. и др. Распределение показателей липидного спектра у мужчин и женщин трудоспособного возраста в Российской Федерации: результаты исследования ЭССЕ-РФ за 2012-2014гг. Кардиоваскулярная терапия и профилактика. 2017;16(4):62-7 doi:10.15829/1728-8800-2017-4-62-67Yerly P, Rodondi N, Viswanathan B, et al. Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population. Int J Cardiovasc Imaging. 2013;29(3):589-99. doi:10.1007/s10554-012-0124-3.Byrne P, Cullinan J, Smith SM. Statins for primary prevention of cardiovascular disease. BMJ. 2019;367:l5674. doi:10.1136/bmj.l5674.Laclaustra M, Casasnovas JA, Fernandez-Ortiz A, et al. Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study. J Am Coll Cardiol. 2016; 67 (1 1): 1263-74. doi: 10.1016/j.jacc.2015.12.056.Milionis H, Ntaios G, Korompoki E, et al. Statin-based therapy for primary and secondary prevention of ischemic stroke: A meta-analysis and critical overview. Int J Stroke. 2019 Sep 7:1747493019873594. doi:10.1177/1747493019873594.Held C, Hjemdahl P, Eriksson SV, et al. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J. 2001;22(1):62-72. doi:10.1053/euhj.1999.2006.Sillesen H, Sartori S, Sandholt B, et al. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging. 2018;19:10421050. doi:10.1093/ehjci/jex239.Colledanchise KN, Mantella LE, Bullen M, et al. Combined Femoral and Carotid Plaque Burden Identifies Obstructive Coronary Artery Disease in Women. J Am Soc Echocardiogr. 2019 Oct 10. pii: S0894-7317(19)3091 1-3. doi:10.1016/j.echo.2019.07024.Polak JF, Szklo M, Kronmal RA, et al. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2013;2(2):e000087 doi:10.1161/JAHA.113.000087.Meshkov AN, Ershova AI, Deev AD, et al. Distribution of lipid profile values in economically active men and women in Russian Federation results of the ESSE-RF study for the years 2012-2014. Cardiovascular Therapy and Prevention. 2017; 16(4):62-7 (In Russ.) doi:10.15829/1728-8800-2017-4-62-67Berard E, Bongard V, Ruidavets JB, et al. Pulse wave velocity, pulse pressure and number of carotid or femoral plaques improve prediction of cardiovascular death in a population at low risk. J Hum Hypertens. 2013;27(9):529-34. doi: 10.1038/jhh.2013.8.Byrne P, Cullinan J, Smith SM. Statins for primary prevention of cardiovascular disease. BMJ. 2019;367:l5674. doi:10.1136/bmj.l5674.Plichart M, Celermajer DS, Zureik M, et al. Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis. 2011;219(2): 917-24. doi: 10.1016/j.atherosclerosis.201 1.09.024.Milionis H, Ntaios G, Korompoki E, et al. Statin-based therapy for primary and secondary prevention of ischemic stroke: A meta-analysis and critical overview. Int J Stroke. 2019 Sep 7:1747493019873594. doi:10.1177/1747493019873594.Johnsen SH, Mathiesen EB, Joakimsen O, et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromse Study. Stroke. 2007;38(11):2873-80. doi:10.1161/STROKEAHA.107.487264.Sillesen H, Sartori S, Sandholt B, et al. Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging. 2018;19:10421050. doi:10.1093/ehjci/jex239.Tada H, Nakagawa T, Okada H, et al. Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events. J AtherosclerThromb. 2019 May 18. doi:10.5551/jat.49551.Polak JF, Szklo M, Kronmal RA, et al. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2013;2(2):e000087 doi:10.1161/JAHA.113.000087.Hirata T, Arai Y, Takayama M, et al. Carotid Plaque Score and Risk of Cardiovascular Mortality in the Oldest Old: Results from the TOOTH Study. J Atheroscler Thromb. 2018;25(1):55-64. doi:10.5551/jat.3791 1.Berard E, Bongard V, Ruidavets JB, et al. Pulse wave velocity, pulse pressure and number of carotid or femoral plaques improve prediction of cardiovascular death in a population at low risk. J Hum Hypertens. 2013;27(9):529-34. doi: 10.1038/jhh.2013.8.Kocyigit D, Gurses KM, Taydas O, et al. Role of femoral artery ultrasound imaging in cardiovascular event risk prediction in a primary prevention cohort at a medium-term follow-up. J Cardiol. 2019 Oct 16. pii: S0914-5087(19)30302-8. doi:10.1016/j.jjcc.2019.09.012.Plichart M, Celermajer DS, Zureik M, et al. Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis. 2011;219(2): 917-24. doi: 10.1016/j.atherosclerosis.201 1.09.024.Gupta A, Kesavabhotla K, Baradaran H, et al. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke. 2015;46( 1 ):91-7 doi: 10.1161/STROKEAHA.114.006091.Johnsen SH, Mathiesen EB, Joakimsen O, et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromse Study. Stroke. 2007;38(11):2873-80. doi:10.1161/STROKEAHA.107.487264.Sabeti S, Schlager O, Exner M, et al. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke. 2007;38(1 1):2887-94. doi:101161/STROKEAHA.107488387Tada H, Nakagawa T, Okada H, et al. Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence of Atherosclerotic Cardiovascular Disease Events. J AtherosclerThromb. 2019 May 18. doi:10.5551/jat.49551.Bertges DJ, Muluk V, Whittle J, et al. Relevance of carotid stenosis progression as a predictor of ischemic neurological outcomes. Arch Intern Med. 2003;163(19):2285-9. doi:10.1001/archinte.163.19.2285.Hirata T, Arai Y, Takayama M, et al. Carotid Plaque Score and Risk of Cardiovascular Mortality in the Oldest Old: Results from the TOOTH Study. J Atheroscler Thromb. 2018;25(1):55-64. doi:10.5551/jat.3791 1.Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33( 12):2916-22. doi: 10.1161/01.str.000004220716156.b9.Kocyigit D, Gurses KM, Taydas O, et al. Role of femoral artery ultrasound imaging in cardiovascular event risk prediction in a primary prevention cohort at a medium-term follow-up. J Cardiol. 2019 Oct 16. pii: S0914-5087(19)30302-8. doi:10.1016/j.jjcc.2019.09.012.Boulos NM, Gardin JM, Malik S, et al. Carotid Plaque Characterization, Stenosis, and Intima-Media Thickness According to Age and Gender in a Large Registry Cohort. Am J Cardiol. 2016; 117(7): 1185-91. doi:101016/j.amjcard.2015.12.062.Gupta A, Kesavabhotla K, Baradaran H, et al. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke. 2015;46( 1 ):91-7 doi: 10.1161/STROKEAHA.114.006091.Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012; 308( 8): 796-803. doi: 10.1001/jama.2012.9630.Sabeti S, Schlager O, Exner M, et al. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke. 2007;38(1 1):2887-94. doi:101161/STROKEAHA.107488387Ежов М. В., Сергиенко И.В, Рожкова Т. А. и др. Диагностика и лечение семейной гиперхолестеринемии (российские рекомендации). Вестник современной клинической медицины. 2017;10(2):72-9. doi:10.20969/VSKM.201710(2).72-79.Bertges DJ, Muluk V, Whittle J, et al. Relevance of carotid stenosis progression as a predictor of ischemic neurological outcomes. Arch Intern Med. 2003;163(19):2285-9. doi:10.1001/archinte.163.19.2285.37 Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33( 12):2916-22. doi: 10.1161/01.str.000004220716156.b9.37 Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33( 12):2916-22. doi: 10.1161/01.str.000004220716156.b9.Boulos NM, Gardin JM, Malik S, et al. Carotid Plaque Characterization, Stenosis, and Intima-Media Thickness According to Age and Gender in a Large Registry Cohort. Am J Cardiol. 2016; 117(7): 1185-91. doi:101016/j.amjcard.2015.12.062.Boulos NM, Gardin JM, Malik S, et al. Carotid Plaque Characterization, Stenosis, and Intima-Media Thickness According to Age and Gender in a Large Registry Cohort. Am J Cardiol. 2016; 117(7): 1185-91. doi:101016/j.amjcard.2015.12.062.Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012; 308( 8): 796-803. doi: 10.1001/jama.2012.9630.Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012; 308( 8): 796-803. doi: 10.1001/jama.2012.9630.Ezhov MV, Sergienko IV, Rozhkova TA, et al. Diagnosis and treatment of family hypercholesterolemia (russian guidelines). The Bulletin of Contemporary Clinical Medicine. 2017; 10(2):72-9. (In Russ.) doi:10.20969/VSKM.201710(2).72-79.Ezhov MV, Sergienko IV, Rozhkova TA, et al. Diagnosis and treatment of family hypercholesterolemia (russian guidelines). The Bulletin of Contemporary Clinical Medicine. 2017; 10(2):72-9. (In Russ.) doi:10.20969/VSKM.201710(2).72-79.

The authors declare that there are no conflicts of interest present.